Recurrent Solid Neoplasm: Clinical Trials

2 trials for Recurrent Solid Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Recurrent Solid Neoplasm: new trials by email Literature Review of Recurrent Solid Neoplasm trials Research Report on Recurrent Solid Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I/Ib Study of Nivolumab & Veliparib in Patients With Advanced Solid Tumors & Lymphoma
Laboratory Biomarker Analysis, Nivolumab, Pharmacological Study - Advanced Solid Neoplasm, Aggressive Non-Hodgkin Lymphoma
Phase 1CompletedNorthwestern University152017-05-232024-06-12
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Laboratory Biomarker Analysis, siRNA-transfected Peripheral Blood Mononuclear Cells (PBMC) APN401 - Metastatic Malignant Neoplasm in the Brain, Metastatic Solid Neoplasm
Phase 1CompletedWake Forest University Health Sciences112017-04-282024-10-10

Narrower conditions

Brain Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Lymphoma, Mantle-Cell (1)  ·  Lymphoma, T-Cell (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Intestinal Diseases (1)

Interventions

Nivolumab (1)  ·  veliparib (1)

Sponsors

Northwestern University (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (2)

Top investigators

Pierre Triozzi (1)  ·  Young K. Chae, MD, MPH, MBA (1)

Results publications

PMID 35362047

NIH funding

P30CA012197 (1), P30CA060553 (1)